| For: | Gao CC, Ding FF, Jiang X. RRM2 attenuates the renal tubular ferroptosis in diabetic kidney disease through PI3K/Akt/Nrf2 pathway. World J Diabetes 2025; 16(11): 111223 [PMID: 41278435 DOI: 10.4239/wjd.v16.i11.111223] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i11/111223.htm |
| Number | Citing Articles |
| 1 |
Lin Chen, Jing Xiao, Ying-Chun Liu. RRM2 attenuates renal tubular ferroptosis in diabetic kidney disease <i>vi</i>a the PI3K/Akt/Nrf2 pathway: Strengths, limitations, and future research directions. World Journal of Diabetes 2026; 17(2): 115021 doi: 10.4239/wjd.v17.i2.115021
|
| 2 |
Min Huang, Bo Xu, Hang Qi, Hongzhou Xu, Liang Cai. Ligustilide alleviates sepsis-associated acute kidney injury by activating Nrf2/HO-1 and PI3K/Akt signaling pathways. The International Journal of Biochemistry & Cell Biology 2026; doi: 10.1016/j.biocel.2026.106945
|
| 3 |
Tong-Jian Zhao, Nian-Zhe Sun. <i>RRM2</i> and the ferroptosis-oxidative stress axis in diabetic kidney disease: Emerging insights from recent evidence. World Journal of Diabetes 2026; 17(8): 115342 doi: 10.4239/wjd.115342
|